Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 10Carcinoma, Intraductal, Noninfiltrating 3Melanoma 2Breast Carcinoma In Situ 2Prostatic Neoplasms 1Precancerous Conditions 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Leukemia 1Hot Flashes 1Hepatitis C 1Fanconi Anemia 1Depression 1Congenital Abnormalities 1

Interventions

fludarabine 2fludarabine phosphate 1Thiotepa 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Microarray Analysis 1Melphalan 1Immunoenzyme Techniques 1Electrophoresis, Polyacrylamide Gel 1Clofarabine 1Chromatography, High Pressure Liquid 1Chromatography 1Blotting, Western 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Fanconi Anemia × Chromatography, High Pressure Liquid × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡